Clifford Swan Investment Counsel’s GSK GSK Stock Holding History

Clifford Swan Investment Counsel’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,048	Closed	-$206K	–	317
2020 Q2	$206K	Buy	+4,048	New	+$208K	0.01%	291
2020 Q1	–	Sell	-3,888	Closed	-$228K	–	308
2019 Q4	$228K	Hold	3,888	–	–	0.01%	294
2019 Q3	$207K	Buy	+3,888	New	+$200K	0.01%	296
2019 Q2	–	Sell	-3,888	Closed	-$203K	–	319
2019 Q1	$203K	Buy	+3,888	New	+$194K	0.01%	296
2018 Q4	–	Sell	-4,128	Closed	-$207K	–	303
2018 Q3	$207K	Hold	4,128	–	–	0.01%	301
2018 Q2	$208K	Sell	4,128 -240	-5%	-$12.1K	0.01%	299
2018 Q1	$213K	Sell	4,368 -288	-6%	-$13.4K	0.01%	294
2017 Q4	$206K	Sell	4,656 -1,224	-21%	-$56.5K	0.01%	304
2017 Q3	$298K	Hold	5,880	–	–	0.02%	256
2017 Q2	$317K	Sell	5,880 -1,092	-16%	-$58.2K	0.02%	253
2017 Q1	$367K	Buy	6,972 +408	+6%	+$20.7K	0.02%	229
2016 Q4	$316K	Sell	6,564 -456	-6%	-$22.5K	0.02%	230
2016 Q3	$378K	Sell	7,020 -560	-7%	-$30.7K	0.03%	215
2016 Q2	$411K	Sell	7,580 -160	-2%	-$8.43K	0.03%	195
2016 Q1	$392K	Hold	7,740	–	–	0.03%	206
2015 Q4	$390K	Hold	7,740	–	–	0.03%	212
2015 Q3	$372K	Hold	7,740	–	–	0.03%	208
2015 Q2	$403K	Sell	7,740 -204	-3%	-$11.5K	0.03%	199
2015 Q1	$458K	Buy	7,944 +320	+4%	+$18.3K	0.03%	192
2014 Q4	$407K	Buy	7,624 +800	+12%	+$44.8K	0.03%	193
2014 Q3	$392K	Sell	6,824 -728	-10%	-$44.6K	0.03%	195
2014 Q2	$505K	Sell	7,552 -1,022	-12%	-$69.2K	0.03%	187
2014 Q1	$573K	Hold	8,574	–	–	0.04%	172
2013 Q4	$572K	Hold	8,574	–	–	0.04%	157
2013 Q3	$538K	Sell	8,574 -464	-5%	-$29.9K	0.04%	156
2013 Q2	$565K	Buy	+9,038	New	+$574K	0.05%	145

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Clifford Swan Investment Counsel's GSK Position: Q3 2020 in Review

Clifford Swan Investment Counsel sold out of GSK (GSK) in Q3 2020, closing a stake of 4,048 shares — an estimated $206K sold.

Clifford Swan Investment Counsel first reported a position in GSK in Q2 2013 and held it in 26 quarters. The position peaked at $573K in Q1 2014. 827 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

Clifford Swan Investment Counsel reported no remaining GSK position as of Q3 2020 after selling out during the quarter.
Clifford Swan Investment Counsel sold 4,048 GSK shares in Q3 2020, an estimated $206K.
Clifford Swan Investment Counsel first reported a position in GSK in Q2 2013 and held it in 26 quarters.
Clifford Swan Investment Counsel's GSK position peaked at $573K in Q1 2014.
827 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Clifford Swan Investment Counsel's 13F filing for Q3 2020, filed 30 Oct 2020.